Dose dependency of earthworm powder on antithrombotic and fibrinolytic effects

  • Yeong Shik Kim
  • Mi Kyung Pyo
  • Kyung Mi Park
  • Bum Soo Hahn
  • Kyung Youl Yang
  • Hye Sook Yun-Choi
Research Articles

DOI: 10.1007/BF02974629

Cite this article as:
Kim, Y.S., Pyo, M.K., Park, K.M. et al. Arch. Pharm. Res. (1998) 21: 374. doi:10.1007/BF02974629

Abstract

The freeze-dried powder ofLumbricus rubellus earthworm was administered orally to rats and its fibrinolytic and antithrombotic effects were investigated. The fibrinolytic activity of plasma was determined by measuring the plasmin activity of the euglobulin fraction and was increased to two-folds of the control at a dose of 0.5g/kg/day and five times with 1 g/kg/day after 4-day administration. The antithrombotic effect was studied in an arterio-venous shunt model of rats. The thrombus weight decreased significantly from 43.2 mg to 32.4 mg at a dose of 0.5g/kg/day after 8-day treatment. The level of fibrinogen/fibrin degradation product (FDP) in serum was elevated in a dose-dependent manner during the treatment period. On the 8th day after administration, the FDP value was increased to 7.7 μg/ml compared with the control value of 3.3 μg/ml. These results support that earthworm powder is valuable for the prevention and/or treatment of thrombotic conditions.

Key words

Lumbricus rubellus earthworm powderAntithrombotic activityFibrinolytic activityArterio-venous shunt model

Copyright information

© The Pharmaceutical Society of Korea 1998

Authors and Affiliations

  • Yeong Shik Kim
    • 2
  • Mi Kyung Pyo
    • 2
  • Kyung Mi Park
    • 2
  • Bum Soo Hahn
    • 2
  • Kyung Youl Yang
    • 1
  • Hye Sook Yun-Choi
    • 2
  1. 1.R&D CenterSamsung Fine Chemicals Co.TaejonKorea
  2. 2.Natural Products Research InstituteSeoul National UniversitySeoulKorea